SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from NANOVIRICIDES, (NNVC) — Jun 11, 2026

NANOVIRICIDES, INC.
Date: June 11, 2026 · CIK: 0001379006 · Accession: 0001104659-26-072869

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-296550

Date
June 11, 2026
Author
/s/ Anil Diwan
Form
CORRESP
Company
NANOVIRICIDES, INC.

Letter

NANOVIRICIDES, INC.

1 Controls Drive

Shelton, Connecticut 06484

June 11, 2026

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Trade and Services

100 F Street, N.E.

Washington, D.C. 20549

Re: NanoViricides, Inc.

Registration Statement on Form S-3

Filed June 5, 2026

File No. 333-296550

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Requested Date: Monday, June 15, 2026

Requested Time: 4:30 p.m., Eastern Time

Ladies and Gentlemen,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, NanoViricides, Inc. (the "Company"), hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form S-3 (File Number 333-296550), as amended so that it will become effective at 4:30 p.m., Eastern Time, on Monday, June 15, 2026, or as soon as practicable thereafter.

Please contact our counsel, Peter Campitiello, Esq. of Lucosky Brookman LLP at (646) 242-7536 with any questions you may have regarding this request. In addition, the Company requests that you kindly notify Mr. Campitiello by telephone when this request for acceleration has been granted

Very truly yours,
/s/ Anil Diwan

Show Raw Text
CORRESP
 1
 filename1.htm

 NANOVIRICIDES, INC.

 1 Controls Drive

 Shelton, Connecticut 06484

 June 11, 2026

 VIA EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 Office of Trade and Services

 100 F Street, N.E.

 Washington, D.C. 20549

 Re:
 NanoViricides, Inc.

 Registration Statement on Form S-3

 Filed June 5, 2026

 File No. 333-296550

 REQUEST FOR ACCELERATION OF EFFECTIVENESS

 Requested Date: Monday, June 15, 2026

 Requested Time: 4:30 p.m., Eastern Time

 Ladies and Gentlemen,

 Pursuant to Rule 461 under
the Securities Act of 1933, as amended, NanoViricides, Inc. (the "Company"), hereby requests acceleration of effectiveness
of the above referenced Registration Statement on Form S-3 (File Number 333-296550), as amended so that it will become effective at 4:30
p.m., Eastern Time, on Monday, June 15, 2026, or as soon as practicable thereafter.

 Please contact our counsel,
Peter Campitiello, Esq. of Lucosky Brookman LLP at (646) 242-7536 with any questions you may have regarding this request. In addition,
the Company requests that you kindly notify Mr. Campitiello by telephone when this request for acceleration has been granted

 Very truly yours,

 /s/ Anil Diwan

 Anil Diwan

 President, Chief Executive Officer, and Chairman